好发表的眼科一区杂志sci

Title: Optical Coherence Tomography Angiography in the Diagnosis and Management of Diabetic Retinopathy

Introduction

Diabetic retinopathy (DR) is a leading cause of vision loss and blindness in working-age individuals around the world. Early diagnosis and management of DR are critical to prevent vision loss. Optical coherence tomography angiography (OCTA), a non-invasive imaging technique that provides high-resolution images of retinal vasculature, has emerged as a valuable tool in the diagnosis and management of DR.

Diagnosis of Diabetic Retinopathy with OCTA

OCTA provides high-resolution images of the retinal vasculature, allowing for the detection of microvascular changes in the retina that precede the onset of clinical symptoms. OCTA has the advantage over traditional imaging modalities, such as fluorescein angiography (FA), that it is non-invasive and does not require the injection of contrast dye, which can induce adverse reactions.

OCTA enables visualization of the retinal vasculature at different depth levels, providing detailed information on the changes in the retinal vasculature that occur in DR. For instance, OCTA has been shown to detect early changes in the superficial capillary plexus (SCP) in patients with diabetes, before the detection of any clinically detectable changes.

Furthermore, OCTA allows for the quantification of retinal vascular parameters, such as vessel density, which can be used to monitor the progression of DR. Vessel density measurements have been shown to be significantly lower in diabetic eyes compared to control eyes, with the degree of vessel density reduction increasing with the severity of DR.

Management of Diabetic Retinopathy with OCTA

OCTA has a role in the management of DR by helping to guide treatment decisions and monitoring the response to treatment. For instance, OCTA can be used to identify eyes with retinal neovascularization, which is an indication for treatment with anti-vascular endothelial growth factor (VEGF) therapy.

OCTA can also be used to monitor the response to treatment with anti-VEGF therapy by measuring changes in the size and density of the neovascularization. In addition, OCTA can be used to monitor the regression of diabetic macular edema, which is also an indication for treatment with anti-VEGF therapy.

Conclusion

In conclusion, OCTA has emerged as a valuable tool in the diagnosis and management of DR. OCTA provides high-resolution images of the retinal vasculature, enabling the early detection of microvascular changes in the retina that precede the onset of clinical symptoms. OCTA also enables the quantification of retinal vascular parameters, which can be used to monitor the progression of DR. Furthermore, OCTA can be used to guide treatment decisions and monitor the response to treatment. OCTA is likely to become an essential tool in the management of DR in the future.